Tuesday, December 2, 2008 - 10:57PM EST

Clinical Trials

1. Fenretinide and risk reduction of second breast cancer.

Author
Decensi A; Zanardi S; Argusti A; Bonanni B; Costa A; Veronesi U; Decensi A; Zanardi S; Argusti A; Bonanni B; Costa A; Veronesi U;
Institution
E.O. Ospedali Galliera, Division of Medical Oncology, Via Volta 6, Genoa 16128, Italy. andrea.decensi@galliera.it
Journal
Nat Clin Pract Oncol. 2007 Feb;4(2):64-5.

2. Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial.

Author
Powles TJ; Ashley S; Tidy A; Smith IE; Dowsett M;
Institution
Parkside Oncology Clinic, 49 Parkside, Wimbledon, London SW19 5NB, UK. hdummer@parkside-hospital.co.uk
Journal
J Natl Cancer Inst. 2007 Feb 21;99(4):283-90.
Abstract URL
Click here to view abstract

3. NSABP B-39, RTOG 0413: A Randomized Phase III Study of conventional whole breast irradiation versus partial breast irradiation for women with stage 0, I, or II breast cancer.

Author
Institution
Journal
Clin Adv Hematol Oncol. 2006 Oct;4(10):719-21.

4. A comparison of quality of life, disease impact and risk perception in women with invasive breast cancer and ductal carcinoma in situ.

Author
van Gestel YR; Voogd AC; Vingerhoets AJ; Mols F; Nieuwenhuijzen GA; van Driel OJ; van Berlo CL; van de Poll-Franse LV; van Gestel YR; Voogd AC; Vingerhoets AJ; Mols F; Nieuwenhuijzen GA; van Driel OJ; van Berlo CL; van de Poll-Franse LV;
Institution
Institute for Health Sciences, Faculty of Earth and Life Sciences, Free University Amsterdam, and Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands.
Journal
Eur J Cancer. 2007 Feb;43(3):549-56. Epub 2006 Nov 30.
Abstract URL
Click here to view abstract

5. Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast.

Author
Holmberg L; Garmo H; Granstrand B; Ringberg A; Arnesson LG; Sandelin K; Karlsson P; Anderson H; Emdin S;
Institution
Division of Cancer Studies, Thomas Guy House, 3rd Floor, King's College London, Guy's Campus, London SE1 9RT, United Kingdom. lars.holmberg@kcl.ac.uk
Journal
J Clin Oncol. 2008 Mar 10;26(8):1247-52. Epub 2008 Feb 4.
Abstract URL
Click here to view abstract

6. Local recurrences after different treatment strategies for ductal carcinoma in situ of the breast: a population-based study in the East Netherlands.

Author
Schouten van der Velden AP; van Vugt R; Van Dijck JA; Leer JW; Wobbes T;
Institution
Department of Surgical Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Journal
Int J Radiat Oncol Biol Phys. 2007 Nov 1;69(3):703-10. Epub 2007 Jun 4.
Abstract URL
Click here to view abstract

7. Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit.

Author
Moore KH; Sweeney KJ; Wilson ME; Goldberg JI; Buchanan CL; Tan LK; Liberman L; Turner RR; Lagios MD; Cody Iii HS; Giuliano AE; Silverstein MJ; Van Zee KJ;
Institution
Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, MRI 1026, New York, NY 10021, USA.
Journal
Ann Surg Oncol. 2007 Oct;14(10):2911-7. Epub 2007 Jun 28.
Abstract URL
Click here to view abstract

8. Women's information needs about ductal carcinoma in situ before mammographic screening and after diagnosis: a qualitative study.

Author
Prinjha S; Evans J; McPherson A;
Institution
DIPEx, Department of Primary Health Care, University of Oxford, Old Road Campus, Oxford OX3 7LF, England. sbprinjha@hotmail.com
Journal
J Med Screen. 2006;13(3):110-4.
Abstract URL
Click here to view abstract

9. The use of radiation as a component of breast conservation therapy in National Comprehensive Cancer Network Centers.

Author
Buchholz TA; Theriault RL; Niland JC; Hughes ME; Ottesen R; Edge SB; Bookman MA; Weeks JC;
Institution
Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. tbuchhol@mdanderson.org
Journal
J Clin Oncol. 2006 Jan 20;24(3):361-9.
Abstract URL
Click here to view abstract

10. Prospective study of wide excision alone for ductal carcinoma in situ of the breast.

Author
Wong JS; Kaelin CM; Troyan SL; Gadd MA; Gelman R; Lester SC; Schnitt SJ; Sgroi DC; Silver BJ; Harris JR; Smith BL; Wong JS; Kaelin CM; Troyan SL; Gadd MA; Gelman R; Lester SC; Schnitt SJ; Sgroi DC; Silver BJ; Harris JR; Smith BL;
Institution
Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA. jwong@lroc.harvard.edu
Journal
J Clin Oncol. 2006 Mar 1;24(7):1031-6. Epub 2006 Feb 6.
Abstract URL
Click here to view abstract
Pages: 1 2